ADMA Biologics, Inc. (ADMA)

15.78 +0.26 (+1.68%) USD  |  NASDAQ  |  Feb 25, 12:09
More

ADMA Biologics Excess Tax Benefit from Stock Compensation (Quarterly)

Excess Tax Benefit from Stock Compensation (Quarterly) Chart

View Excess Tax Benefit from Stock Compensation (Quarterly) for ADMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Excess Tax Benefit from Stock Compensation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Excess Tax Benefit from Stock Compensation (Quarterly) Range, Past 5 Years

View Excess Tax Benefit from Stock Compensation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Excess Tax Benefit from Stock Compensation (Quarterly) Benchmarks

View Excess Tax Benefit from Stock Compensation (Quarterly) Benchmarks
Start Trial
Marker Therapeutics, Inc. --
Arcutis Biotherapeutics, Inc. --
CorMedix, Inc. --
AtriCure, Inc. --
Ligand Pharmaceuticals, Inc. --